News
Eli Lilly's oral GLP-1 drug orforglipron showed strong Phase 3 results with 7.9% weight loss and good tolerability, ...
The results bring Eli Lilly's pill orforglipron one step closer to becoming a new, needle-free alternative in the booming ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback